Showing results (251-260 of 3,274) with videos related to
Sort By:
Pageof 328
Japanese Journal of Pharmacology|October 1, 1986
A beta-adrenergic partial agonist (befunolol) discriminates two different affinity sitesK Koike, I TakayanagiComparative Biochemistry and Physiology. A, Comparative Physiology|January 1, 1988
Coexistence of FMRFamide, met-enkephalin and serotonin in molluscan neuronsH Takayanagi, N TakedaJournal of Pharmacobio-Dynamics|September 1, 1987
Interactions of befunolol, a beta-adrenergic partial agonist, and its derivatives with high and low affinity sites in beta-adrenoceptorsK Koike, I TakayanagiJournal of Cataract and Refractive Surgery|September 18, 2017
Comparison of refractive and keratometric astigmatism after microincision cataract surgeryAtsushi Kawahara, Yoshinori TakayanagiAdvances in Immunology|May 22, 2012
Autoimmune arthritis: the interface between the immune system and jointsNoriko Komatsu, Hiroshi TakayanagiGeneral Pharmacology|January 1, 1985
A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organsI Takayanagi, K KoikePhysical Chemistry Chemical Physics : PCCP|September 8, 2020
Franck-Condon simulations of transition-state spectra for the OH + H2O and OD + D2O reactionsYutaro Sugiura, Toshiyuki TakayanagiGeneral Pharmacology|January 1, 1991
Effects of aging on postsynaptic alpha 1-adrenoceptor mechanisms in rat aortaI Takayanagi, K KoikePharmacology & Toxicology|November 1, 1996
The enhancing effect of tumour necrosis factor-alpha on oxidative stress in endotoxemiaS Sakaguchi, S Furusawa, K Yokota, et al.Biological & Pharmaceutical Bulletin|November 1, 1996
Effects of antitumor activity and protection of shock symptoms by a traditional Chinese medicine (sho-saiko-to) in recombinant human tumor necrosis factor administered miceS Sakaguchi, S Furusawa, K Yokota, et al.Pageof 328